Hepatitis A, Total 

Laboratory Fee Schedule

Procedure: MBE0203A

CPT: 86708

Hepatitis A, Total
Synonym(s): Enzyme Immunoassay (EIA) for the Detection of total Anti-Hepatitis A Antibodies (IgG and IgM) in Human Serum
Requisition Form G-2A
Test Description An in vitro enzyme immunoassay for the qualitative detection of total antibodies (IgG and IgM) to hepatitis A virus in human serum
Pre-Approval Needed N/A
Supplemental Information Required N/A
Supplemental Form(s) N/A
Performed on Specimens from (sources) Human
Sample/Specimen Type for Testing Serum
Minimum Volume/Size Required 500 µL
Storage/Preservation Prior to Shipping Serum separated from the clot may be stored at 2°C to 8°C for up to 48 hours but then must be frozen at -20°C or colder until used.
Transport Medium N/A
Specimen Labeling At least 2 patient specific identifiers: First and last name as one identifier and a DOB or a unique patient specific identifier (e.g. Medical Record number); must match information on submission form (G-2A).
Shipping and Specimen Handling Requirements
  • Ship according to Dangerous Goods Regulations, IATA, and/or CFR 49.
  • Handle as infectious agent using universal precautions.
  • Triple contain in accordance with federal shipping regulations for infectious agents.
    Additional forms & resources
Method EIA for antibody detection
Turn-around Time 5 days
Interferences/Limitations Bacterial contamination,  heterophile antibodies
Causes for Rejection Insufficient quantity, unacceptable specimen type or source, improper shipping conditions, expired media or collection container, discrepancies between specimen label and submission form, and/or incomplete or missing submission form.
Additional Information A reactive HAV result does not exclude co-infection by another hepatitis virus.

Last updated October 31, 2017